Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Cited by (1,012)

Items 801–900 of 1,012

1. COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
   Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, Tatjana Potpara, Herbert D. Aronow, Luis Jara‐Palomares, Michelle Sholzberg, Dominick Joseph Angiolillo, Gregory Y.H. Lip, Behnood Bikdeli · 2022 · Seminars in Thrombosis and Hemostasis
2. COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
   Catharina Belge, Rozenn Anne Quarck, Laurent Godinas, David Montani, Pilar Escribano Subías, Jean‐Luc Vachiéry, Heba Nashat, Joanna Pepke‐Żaba, Marc J.C. Humbert, Marion Delcroix · 2020 · ERJ Open Research
3. Residual Lung Injury in Patients Recovering From COVID ‐19 Critical Illness
   Abdulrahman Mishaal Alharthy, Mohamed Abuhamdah, Abdullah Balhamar, Fahad Ali Faqihi, Nasir Nasim, Shahzad Ahmad, Alfateh Sayed Nasr Noor, Hani Tamim, Saleh A. Alqahtani, Ahad Alhassan Al Saud et al. · 2020 · Journal of Ultrasound in Medicine
4. Circulating histones play a central role in COVID-19-associated coagulopathy and mortality
   Rebecca Shaw, Simon Timothy Abrams, James A. Austin, Joseph M. Taylor, Steven Lane, Tina Dutt, Colin Downey, Min Du, Lance C. W. Turtle, John Kenneth Baillie et al. · 2021 · Haematologica
5. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications
   Ming Sheng Lim, Simon J. McRae · 2021 · Critical Reviews in Oncology/Hematology
6. The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders
   Upasana Parthasarathy, Roberta Martinelli, Elisabeth H. Vollmann, Katharine Best, Alex G. Therien · 2021 · Biochemical Pharmacology
7. Gastrointestinal Involvement in SARS-CoV-2 Infection
   Tsung‐Hsien Chen, Ming‐Tse Hsu, Ming‐Yang Lee, Chu‐Kuang Chou · 2022 · Viruses
8. COVID-19 Guide for the Rehabilitation Clinician
   Marielisa Lopez, Kathleen Reilly Bell, Thiru M. Annaswamy, Shannon B. Juengst, Nneka L. Ifejika · 2020 · American Journal of Physical Medicine & Rehabilitation
9. Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients
   Fei Mei, Jiawei Fan, Jinhua Yuan, Zhenzhen Liang, Kewei Wang, Jianfeng Sun, Wenfei Guan, Mingkui Huang, Li Yu, Wayne W. Zhang · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
10. Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
    Flavio Cadegiani, Carlos Gustavo Wambier, Andy Goren · 2020 · Frontiers in Medicine
11. Hemostatic Abnormalities in COVID-19: An Update
    Mukul Aggarwal, Jasmita Dass, Manoranjan Mahapatra · 2020 · Indian Journal of Hematology and Blood Transfusion
12. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19
    Eileen M. McGowan, Nahal Haddadi, Najah Therese Nassif, Yiguang Lin · 2020 · International Journal of Molecular Sciences
13. WGO Guidance for the Care of Patients With COVID-19 and Liver Disease
    S. Hamid, M. Álvares da Silva, K. Burak, Tao Chen, J. Drenth, G. Esmat, R. Gaspar, D. Labrecque, A. Lee, G. Macedo et al. · 2020 · Journal of Clinical Gastroenterology
14. Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation
    Anne‐Marije Hulshof, Renée A. G. Brüggemann, Mark M. G. Mulder, Tom W. van de Berg, Jan-Willem E. M. Sels, Renske H. Olie, Bart Spaetgens, Alexander S. Streng, Paul Verhezen, Iwan C.C. van der Horst et al. · 2021 · Frontiers in Cardiovascular Medicine
15. Acute limb ischemia among patients with COVID-19 infection
    George C. Galyfos, Argiri Sianou, Maximos Frountzas, Kotsarinis Vasilios, Dimitrios Vouros, Charalampos Theodoropoulos, Victoria Michalopoulou, Frangiska Sigala, Konstantinos Filis · 2021 · Journal of Vascular Surgery
16. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2
    Siya Kamat, Madhuree Kumari, Chelliah Jayabaskaran · 2021 · Journal of Controlled Release
17. CT-derived pulmonary vascular metrics and clinical outcome in COVID-19 patients
    Pietro Spagnolo, Andrea Cozzi, Riccardo Foà, Angelo Spinazzola, Lorenzo Monfardini, Claudio Bnà, Marco Alì, Simone Schiaffino, Francesco Sardanelli · 2020 · Quantitative Imaging in Medicine and Surgery
18. Clinically significant anticardiolipin antibodies associated with COVID-19
    Sami Hossri, Mahmoud Shadi, Zaid Hamarsha, Rick Schneider, DANY E ELSAYEGH · 2020 · Journal of Critical Care
19. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective
    Azita H. Talasaz, Hessam Kakavand, Benjamin W. Van Tassell, Maryam Aghakouchakzadeh, Parham Sadeghipour, Steven P. Dunn, Babak Geraiely · 2020 · Cardiovascular Drugs and Therapy
20. Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
    Kholoud F. Aliter, Rami A. Al‐Horani · 2020 · Cardiovascular Drugs and Therapy
21. Nonlinear, dissipative phenomena in whole blood clot mechanics
    Gabriella P. Sugerman, Sapun H. Parekh, Manuel K. Rausch · 2020 · Soft Matter
22. Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19
    Cristina Rodríguez, Neus Luque, Isabel Blanco, Laura Sebastián, Joan Albert Barberà, Víctor I. Peinado, Olga Tura-Ceide · 2020 · American Journal of Respiratory Cell and Molecular Biology
23. Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO
    Alexander S. Streng, Thijs Delnoij, Mark M. G. Mulder, Jan-Willem E. M. Sels, Rick J. H. Wetzels, Paul Verhezen, Renske H. Olie, Jeroen Peter Kooman, Sander M. J. van Kuijk, Lloyd Brandts et al. · 2020 · TH Open
24. Post COVID-19 Ophthalmic Manifestations in an Asian Indian Male
    Srinivasan Sanjay, Priya Srinivasan, Chaitra Jayadev, Padmamalini Mahendradas, Aditi Gupta, Ankush Kawali, Rohit Shetty · 2021 · Ocular Immunology and Inflammation
25. Platelet-Mediated NET Release Amplifies Coagulopathy and Drives Lung Pathology During Severe Influenza Infection
    Seok‐Joo Kim, Agostina Carestia, Braedon McDonald, Amanda Zaparoli Zucoloto, Heidi A.I. Grosjean, Rachelle P. Davis, Madison Turk, Victor Naumenko, Silvio Antoniak, Nigel Mackman et al. · 2021 · Frontiers in Immunology
26. Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019
    Garcia-Vidal, Carolina, Moreno-García, Estela, Hernández-Meneses, Marta, Puerta-Alcalde, Pedro, Chumbita, Mariana, Garcia-Pouton, Nicole, Linares, Laura, Rico, Verónica, Cardozo, Celia, Martínez, José Antonio et al. · 2022 · Clinical Infectious Diseases
27. The continuing evolution of COVID-19 imaging pathways in the UK: a British Society of Thoracic Imaging expert reference group update
    Samanjit S Hare, Jonathan C. L. Rodrigues, Arjun Nair, Joseph Jacob, S. Upile, Annette Johnstone, Ruth McStay, Anthony Edey, Graham Robinson · 2020 · Clinical Radiology
28. Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
    Christopher D. Barrett, Hunter B. Moore, Ernest Eugene Moore, Robert C. McIntyre, Peter K. Moore, John Burke, Fei Hua, Joshua F. Apgar, Daniel S. Talmor, Angela Sauaia et al. · 2020 · Research and Practice in Thrombosis and Haemostasis
29. Effect of COVID-19 on Emergent Stroke Care
    Jessica Hsiao, Emily Sayles, Eleni Antzoulatos, Robert J. Stanton, Heidi J. Sucharew, Joseph P. Broderick, Stacie L Demel, Matthew L. Flaherty, Aaron W. Grossman, Charles E Kircher et al. · 2020 · Stroke
30. Screening and testing for COVID ‐19 before surgery
    Joshua George Kovoor, David R. Tivey, Penny Williamson, Lorwai Tan, Helena S. Kopunic, Wendy Babidge, Trevor G. Collinson, Peter J. Hewett, Thomas J. Hugh, Robert T. A. Padbury et al. · 2020 · ANZ Journal of Surgery
31. COVID-19 Neurological Manifestations and Underlying Mechanisms: A Scoping Review
    Angela Wenting, Angélique A.A. Gruters, Yindee van Os, Sonja Verstraeten, Susanne A.M. Valentijn, Rudolf Ponds, Marjolein Elizabeth de Vugt · 2020 · Frontiers in Psychiatry
32. Thrombosis and COVID-19: The Potential Role of Nutrition
    Αλέξανδρος Τσούπρας, Ronan Lordan, Ioannis Zabetakis · 2020 · Frontiers in Nutrition
33. Management of critically ill patients with COVID-19: suggestions and instructions from the coordination of intensive care units of Lombardy
    Giuseppe Foti, COVID-19 Lombardy ICU Network, Alberto Giannini, Nicola Bottino, Gian Paolo Castelli, Maurizio Cecconi, Giacomo Grasselli, Luca Guatteri, Nicola Latronico, Thomas Länger et al. · 2020 · Minerva Anestesiologica
34. Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism
    Mohamed Abu‐Farha, Salman K Al-Sabah, Maha M. Hammad, Prashantha Hebbar, Arshad Mohamed Channanath, Sumi Elsa John, Ibrahim Taher, Abdulrahman Hamdan Almaeen, Amany A. Ghazy, Anwar Mohammad et al. · 2020 · Frontiers in Pharmacology
35. Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity
    Mahin Behzadifard, Samaneh Behzadi Fard, Shahin Ramazi, Amir Atashi, Zahra Eslamifar · 2021 · Thrombosis Journal
36. COVID-19: Beta-Thalassemia Subjects Immunised?
    Édouard Lansiaux, Philippe Pébaÿ, Jean-Laurent Picard, Joachim Forget · 2020 · Medical Hypotheses
37. Early Insights into Immune Responses during COVID-19
    Ashley L. St. John, Abhay P. S. Rathore · 2020 · The Journal of Immunology
38. Cold Agglutinin Disease and Autoimmune Hemolytic Anemia with Pulmonary Embolism as a Presentation of COVID-19 Infection
    Neha Patil, Erica S. Herc, Marian Girgis · 2020 · Hematology/Oncology and Stem Cell Therapy
39. High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019
    Émile Ferrari, Benjamin Sartre, Fabien Squara, Julie Contenti, Céline Occelli, Fabien Lemoël, J. Levraut, Denis Doyen, Jean Dellamonica, V. Mondain et al. · 2020 · Journal of the American Heart Association
40. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism
    Firdos Ahmad, Meganathan Kannan, Abdul Wahid Ansari · 2021 · Cytokine & Growth Factor Reviews
41. ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition—implications for COVID-19
    Julia S. El-Sayed Moustafa, Anne Jackson, Sarah M. Brotman, Li Guan, Sergio Villicaña, Amy L. Roberts, Antonino Zito, Lori L. Bonnycastle, Michael R. Erdos, Narisu Narisu et al. · 2022 · International Journal of Obesity
42. Prothrombotic phenotype in COVID-19 severe patients
    Julie Helms, François Séverac, Hamid Merdji, Eduardo Anglés‐Cano, Ferhat Meziani · 2020 · Intensive Care Medicine
43. Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
    Omar Hasan Ali, David Bomze, Lorenz Risch, Silvio D. Brugger, Matthias Paprotny, Myriam C. Weber, Sarah L. Thiel, Lukas Kern, Werner C. Albrich, Philipp P. Kohler et al. · 2021 · Clinical Infectious Diseases
44. SCOR: A secure international informatics infrastructure to investigate COVID-19
    Raisaro, J L, Marino, Francesco, Troncoso-Pastoriza, Juan, Beau-Lejdstrom, Raphaelle, Bellazzi, Riccardo, Murphy, Robert, Bernstam, Elmer V, Wang, Henry, Bucalo, Mauro, Chen, Yong et al. · 2020 · Journal of the American Medical Informatics Association
45. Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19
    Javier Abel Menéndez · 2020 · Aging
46. Collateral damage – Impact of a pandemic on stroke emergency services
    Shashvat M. Desai, Francis Xavier Guyette, Christian Martin‐Gill, Ashutosh Prabhakar Jadhav · 2020 · Journal of Stroke and Cerebrovascular Diseases
47. Neurobiology of coronaviruses: Potential relevance for COVID-19
    Mauro Cataldi, Giuseppe Pignataro, Maurizio Taglialatela · 2020 · Neurobiology of Disease
48. Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis
    Shanen Jin, Yiyang Jin, Xu Bai, Jun Hong, Xianghong Yang · 2020 · Thrombosis and Haemostasis
49. Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19
    Gustavo Adolfo Argañaraz, Julys da Fonseca Palmeira, Enrique Roberto Argañaraz · 2020 · Cell Communication and Signaling
50. Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection
    Alberto García‐Ortega, Grace Oscullo, Pilar Calvillo, Raquel López-Reyes, Raúl Méndez, José Daniel Gómez-Olivas, Amina Bekki, Carles Fonfría, Laura Trilles-Olaso, Enrique Zaldívar et al. · 2021 · Journal of Infection
51. Retinal microvascular signs in COVID-19
    Ralene Zi Hui Sim, Chui Ming Gemmy Cheung, Daniel Shu Wei Ting, Edmund YM Wong, Tien Yin Wong, Ian Y. S. Yeo, Chee Wai Wong · 2021 · British Journal of Ophthalmology
52. COVID‐19‐related coagulopathy: A review of pathophysiology and pharmaceutical management
    Mahdi Kohansal Vajari, Mahsa Shirin, Atieh Pourbagheri‐Sigaroodi, Mohammad Esmaeil Akbari, Hassan Abolghasemi, Davood Bashash · 2021 · Cell Biology International
53. Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐19
    Karola Jering, Martina M. McGrath, Finnian R. Mc Causland, Brian Lee Claggett, Jonathan W. Cunningham, Scott David Solomon · 2021 · Clinical Transplantation
54. Comorbidities, Associated Diseases, and Risk Assessment in COVID‐19—A Systematic Review
    Andreea Fitero, SIMONA GABRIELA BUNGAU, Delia Mirela Ţiţ, Laura Maria Endres, Shamim Ahmad Khan, Alexa Florina Bungău, Ioana Mihaela Romanul, Cosmin Mihai Vesa, Andrei-Flavius Radu, Alexandra Georgiana Tarce et al. · 2022 · International Journal of Clinical Practice
55. Chronic Lung Injury after COVID-19 Pneumonia: Clinical, Radiologic, and Histopathologic Perspectives
    Min Jae Cha, Joshua J. Solomon, Jong Eun Lee, Hyewon Choi, Kum Ju Chae, Kyung Soo Lee, David A. Lynch · 2024 · Radiology
56. Coronavirus Disease 2019 and the Cerebrovascular‐Cardiovascular Systems: What Do We Know So Far?
    Anthony S. Larson, Luis Emilio Savastano, Ramanathan Kadirvel, David F. Kallmes, Ameer E Hassan, Waleed Brinjikji · 2020 · Journal of the American Heart Association
57. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion
    Caterina Vacchi, Marianna Meschiari, Jovana Milić, Marco Marietta, Roberto Tonelli, Gaetano Alfano, Sara Volpi, Matteo Faltoni, Giacomo Franceschi, Giacomo Ciusa et al. · 2020 · Lara D. Veeken
58. Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines
    Angelo Porfidia, Roberto Pola · 2020 · Journal of Thrombosis and Thrombolysis
59. Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells
    Sayed Ausim Azizi, Saara‐Anne Azizi · 2020 · Journal of NeuroVirology
60. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action
    Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, Caterina Stera, Tommaso Meconi, Francesca Covani Frigieri · 2020 · Thrombosis Research
61. Repurposing existing drugs for COVID-19: an endocrinology perspective
    Flavio Cadegiani · 2020 · BMC Endocrine Disorders
62. Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
    Girish Pathangey, Priyal Fadadu, Alexa R. Hospodar, Amr E. Abbas · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
63. Delayed pulmonary embolism after COVID-19 pneumonia: a case report
    Mohamad Kanso, Thomas Cardi, Halim Marzak, Alexandre Schatz, Loïc Faucher, L. Grunebaum, Olivier Morel, Laurence Jesel · 2020 · European Heart Journal - Case Reports
64. Pulmonary thrombosis in Covid-19: before, during and after hospital admission
    Maria Vlachou, Anja B. Drebes, Luciano Candilio, Deshan Weeraman, Naheed Mir, Nick R Murch, Neil Davies, Gerry Coghlan · 2021 · Journal of Thrombosis and Thrombolysis
65. Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
    Mitja Jevnikar, Olivier Sanchez, Richard Chocron, Marc Andronikof, Maurice Raphaël, Olivier Meyrignac, Laure S Fournier, David Montani, Benjamin Planquette, Mary Soudani et al. · 2021 · European Respiratory Journal
66. Therapeutic strategies to fight COVID‐19: Which is the status artis?
    Cristina Scavone, Annamaria Mascolo, Concetta Rafaniello, Liberata Sportiello, Ugo Trama, Alice Zoccoli, Francesca Futura Bernardi, Giorgio Racagni, Liberato Berrino, Giuseppe Castaldo et al. · 2021 · British Journal of Pharmacology
67. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline
    Jeffrey D. Pyne, Adam M. Brickman · 2021 · Neurodegenerative Diseases
68. Venous Thromboembolism in COVID-19 Compared to Non-COVID-19 Cohorts: A Systematic Review with Meta-Analysis
    Antonella Tufano, Domenico Rendina, Veronica Abate, Aniello Casoria, Annachiara Marra, Pasquale Buonanno, Ferruccio Galletti, Giovanni Di Minno, Giuseppe Servillo, Maria Vargas · 2021 · Journal of Clinical Medicine
69. Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients
    Angela Genchi, Aurora Semerano, Ghil Schwarz, Beatrice Dell’Acqua, Giorgia Serena Gullotta, Michela Sampaolo, Enzo Boeri, Angelo Quattrini, Francesca Sanvito, Susanna Diamanti et al. · 2022 · Acta Neuropathologica Communications
70. Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients
    Yu Lai Yuan, Jie Tu, Bingxin Lei, Huaqing Shu, Xiaojing Zou, Ruiting Li, Chaolin Huang, Yali Qu, You Shang · 2020 · Clinical and Applied Thrombosis/Hemostasis
71. Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19
    Zheng Cai, Mark Irwin Greene, Zhiqiang Zhu, Hongtao Zhang · 2020 · Antibodies
72. Arterial and venous thromboembolic disease in a patient with COVID-19: A case report
    Renée A. G. Brüggemann, Hester A. Gietema, Borefore P. Jallah, Hugo Ten Cate, Coen D.A. Stehouwer, Bart Spaetgens · 2020 · Thrombosis Research
73. Neurologic Involvement in COVID-19: Cause or Coincidence? A Neuroimaging Perspective
    Albert Pons‐Escoda, Pablo Naval‐Baudin, Carles Majós, Àngels Camins, Pedro Cardona, Mònica Cos, Nahum Calvo · 2020 · American Journal of Neuroradiology
74. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review
    Peter Brendon Sherren, Marlies Ostermann, Sangita Agarwal, Christopher I. S. Meadows, Nicholas Ioannou, Luigi Camporota · 2020 · British Journal of Anaesthesia
75. Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
    Mouhand Faisal Hamad Mohamed, Shaikha D. Al-Shokri, Khaled M. Shunnar, Sara F. Mohamed, Mostafa Najim, Shahd I. Ibrahim, Hazem Fathy Elewa, Khalid M Dousa, Lina O. Abdalla, Ahmed El‐Bardissy et al. · 2021 · Frontiers in Cardiovascular Medicine
76. Radiological management and follow-up of post-COVID-19 patients
    Javier Alarcón-Rodríguez, M. Fernández-Velilla, Almudena Ureña-Vacas, Jesús Javier Martín-Pinacho, J.A. Rigual-Bobillo, Ana Jaureguízar Oriol, Luis Gorospe‐Sarasúa · 2021 · Radiología (English Edition)
77. Decreased Serum Selenium Levels of COVID-19 Patients in Comparison with Healthy Individuals
    Ommolbanin Younesian, Behnaz Khodabakhshi, Nafiseh Abdolahi, Alireza Norouzi, Nasser Behnampour, Sara Hosseinzadeh, Seyedeh Somayeh Hosseini Alarzi, Hamidreza Joshaghani · 2021 · Biological Trace Element Research
78. Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19
    Matthew J. Flick, Kadri Kangro, Alisa S. Wolberg · 2022 · Current Drug Targets
79. Venous thromboembolism: Why is it still a significant health problem?
    Monika Oleksiuk-Bójko, Anna Lisowska · 2022 · Advances in Medical Sciences
80. COVID-19 : physiopathologie d’une maladie à plusieurs visages
    Vincent Bonny, Alexis Maillard, Cyril Mousseaux, Léo Plaçais, Quentin Richier · 2020 · La Revue de Médecine Interne
81. A case of adrenal infarction in a patient with COVID 19 infection
    Raekha Kumar, Thushyanthan Guruparan, Safa Siddiqi, Roosey Sheth, Meron R Jacyna, Mani Naghibi, Eirini Vrentzou · 2020 · BJR|case reports
82. Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study
    Reza Nejat, Ahmad Shahir Sadr · 2020 · In Silico Pharmacology
83. Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients
    Sébastian Voicu, Chahinez Ketfi, Alain Stépanian, Benjamin Glenn Chousterman, Nassim Mohamedi, Virginie Siguret, Alexandre Mebazaa, Bruno Mégarbane, Philippe Bonnin · 2021 · Frontiers in Physiology
84. Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity
    Prem Rajak, Abhratanu Ganguly, Saurabh Sarkar, Moutushi Mandi, Moumita Dutta, Sayanti Podder, Salma Khatun, Sumedha Roy · 2021 · Food and Chemical Toxicology
85. Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
    Daniela Mokrá, Juraj Mokrý · 2021 · International Journal of Molecular Sciences
86. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19
    Ana I. Hernández Cordero, Xuan Li, Stephen B Milne, Chen Xi Yang, Yohan Bossé, Philippe Joubert, Wim Timens, Maarten van den Berge, David C. Nickle, Ke Hao et al. · 2021 · Human Genetics
87. Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients
    Martin Martinot, Magali Eyriey, Simon Gravier, Thomas Bonijoly, Damien Kayser, C. Ion, Mahsa Mohseni-Zadeh, S. Camara, Jasperina Dubois, E. Haerel et al. · 2021 · Infectious Diseases Now
88. Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects
    Daniella M. Mizurini, Eugênio Damaceno Hottz, Patrícia Torres Bozza, Robson Q. Monteiro · 2021 · Frontiers in Cardiovascular Medicine
89. Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature
    Abdullah Obaid Khan, Jasmeet Singh Reyat, Harriet J. Hill, Joshua H. Bourne, Martina Colicchia, Maddy L. Newby, Joel D. Allen, Max Crispin, Esther Youd, Paul Gerard Murray et al. · 2022 · Cardiovascular Research
90. Activation of ang-(1-7)/mas receptor is a possible strategy to treat coronavirus (SARS-CoV-2) infection
    Magalhaes, Giselle Santos, Rodrigues-Machado, Maria da Gloria, Motta-Santos, Daisy, Campagnole-Santos, Maria Jose, Santos, Robson A. Souza · 2020 · Frontiers in Physiology
91. Anticoagulation practice patterns in COVID‐19: A global survey
    Rachel Pam Greenerger Rosovsky, Kristen Marie Sanfilippo, Tzu‐Fei Wang, Sandeep Kumar Rajan, Surbhi Shah, Karlyn A. Martin, Fionnuala Ní Áinle, Menno Volkert Huisman, Beverley Jane Hunt, Susan Rebecca Kahn et al. · 2020 · Research and Practice in Thrombosis and Haemostasis
92. Arterial thrombotic complications in COVID-19 patients
    Stef Levolger, Reinoud P.H. Bokkers, Jan C. Wille, Rogier H. J. Kropman, J.P.P.M. de Vries · 2020 · Journal of Vascular Surgery Cases and Innovative Techniques
93. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
    Mauro Giorgi, Silvia Cardarelli, Federica Ragusa, Michele Saliola, Stefano Biagioni, Giancarlo Poiana, Fabio Naro, Mara Massimi · 2020 · International Journal of Molecular Sciences
94. Thoracic Imaging Findings of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: What Radiologists Need to Know Now
    Abbey J. Winant, Einat Blumfield, Mark C. Liszewski, Jessica Kurian, Alexandra M. Foust, Edward Y. Lee · 2020 · Radiology Cardiothoracic Imaging
95. Decreased serial scores of severe organ failure assessments are associated with survival in mechanically ventilated patients; the prospective Maastricht Intensive Care COVID cohort
    Julia L.M. Bels, Sander M. J. van Kuijk, Chahinda Ghossein‐Doha, Fabian H. Tijssen, Rob J. J. van Gassel, Jeanette Tas, MaastrICCht Collaborators, Ronny M. Schnabel, Marcel J H Aries, Iwan C.C. van der Horst et al. · 2020 · Journal of Critical Care
96. SARS-CoV-2 infection and thrombotic complications: a narrative review
    Iraklis C. Moschonas, Alexandros D. Tselepis · 2021 · Journal of Thrombosis and Thrombolysis
97. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment
    Jinwen Luo, Xiao Zhu, Jie Jian, Xu Chen, Kai Yin · 2020 · Acta Biochimica et Biophysica Sinica
98. Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study
    Sajid Hameed, Mohammad Wasay, Bashir Ahmed Soomro, Malek Mansour, Foad Abd-Allah, Tian Ming Tu, Raja Farhat, Naila Shahbaz, Husnain Hashim, Wasim Alamgir et al. · 2021 · Cerebrovascular Diseases Extra
99. The Long Term Residual Effects of COVID-Associated Coagulopathy
    Marco Ranucci, Ekaterina Baryshnikova, Martina Anguissola, Sara Pugliese, Mara Falco, Lorenzo Menicanti · 2023 · International Journal of Molecular Sciences
100. COVID-19: clinical issues from the Japan Surgical Society
     Masaki Mori, Norihiko Ikeda, Akinobu Taketomi, Yoh Asahi, Yoshio Takesue, Tatsuya Orimo, Minoru Ōno, Takashi Kuwayama, Seigo Nakamura, Yohei Yamada et al. · 2020 · Surgery Today